eLearning modules
Find out when levodopa therapy may be initiated and discover how catechol-O-methyltransferase (COMT) inhibitors may be used in conjunction with levodopa to help control motor symptoms in patients with Parkinson’s disease (PD). In these interactive eLearning modules, the expert faculty address important questions in the field of PD research, providing insight into the steps that can be taken to optimise patient outcomes.
Levodopa is considered the gold standard of treatment in Parkinson’s disease, but there is still some debate as to when levodopa therapy should be initiated.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Diagnosing motor fluctuations in patients with Parkinson’s disease can be challenging, particularly in early-stage disease.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority in collaboration with BIAL, with content provided by BIAL. Job code: ON/FEV20/G/183. Module 1: Date of publication July 2020 ON/JUL20/G/386. Module 2: Date of publication November 2020 ON/NOV20/G/458.